I followed the company for years. Friends had melanomas removed. My Dad died as a result of melanoma tumors on the brain.
While camping I reviewed everything I knew about the product and company with a friend who also happens to be chief of staff in a Dallas hospital. He called the company in for a demonstration and brought along some of his dermatologists.
They were floored. The analogy they made was that MELAFIND is as revolutionary to melanoma detection as the PAP Smear was to cervical cancer detection.
The primary reason they didn't buy the machine was because there is no insurance company reimbursement yet. They would essentially have to "sell" the test. There were a few other issues we identified. MELA announced afterwards they identified all of the drawbacks we recognized and they are addressing them.
My friends bought a lot of the stock, not the machine.
If you don't read all of my old MELA posts, read the one I posted today.
There are some big money players getting behind them who are risking tremendous amounts of money. I like to follow the smart money.
Recent QUIK News
- QuickLogic Releases Aurora 2.6 with Expanded Operating System Support and Up to 15% Faster Performance • PR Newswire (US) • 05/01/2024 12:00:00 PM
- QuickLogic to Showcase FPGA/eFPGA Expertise at HEART Conference • PR Newswire (US) • 04/11/2024 06:00:00 PM
- SensiML at Embedded World 2024 • PR Newswire (US) • 04/04/2024 12:30:00 PM
- QuickLogic Announces Radhika Krishnan Stepping Down From its Board of Directors • PR Newswire (US) • 04/01/2024 08:05:00 PM
- QuickLogic and Zero-Error Systems Partner to Deliver Radiation-Tolerant eFPGA IP for Commercial Space Applications • PR Newswire (US) • 03/14/2024 12:07:00 PM
- QuickLogic to Exhibit at GOMACTech 2024 • PR Newswire (US) • 03/13/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 10:34:12 PM
- QuickLogic Announces eFPGA IP Contract for TSMC N12e™ Process Technology • PR Newswire (US) • 03/05/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:16:58 PM
- QuickLogic Signs 7-Figure eFPGA IP Contract for GlobalFoundries' 12LP Process • PR Newswire (US) • 02/28/2024 01:05:00 PM
- QuickLogic Reports Record Fourth Quarter Net Income and Full Year 2023 Non-GAAP Profitability • PR Newswire (US) • 02/27/2024 09:32:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:39:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:42:34 PM
- QuickLogic to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Tuesday, February 27, 2024 • PR Newswire (US) • 02/13/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:15:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:15:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:15:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:52:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:48:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:47:37 AM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 02/06/2024 12:46:49 AM
- QuickLogic at Chiplet Summit: CEO Panel Participation and Showcase eFPGAs • PR Newswire (US) • 02/01/2024 01:30:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/04/2024 10:11:25 PM
- SensiML Unveils Data Studio - Next-Generation Sensor Data Management for AI / ML • PR Newswire (US) • 12/19/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:39:49 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM